Clinical Trial Update: Immunosuppressant Combined With Pirfenidone in CTD-ILD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating an immunosuppressant in combination with pirfenidone for connective tissue disease-associated interstitial lung disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease-associated Interstitial Lung Disease

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Pirfenidone, Connective Tissue Diseases | Phase 4 | Status: UNKNOWN